Multisociety clinical practice guidance says most patients can continue GLP-1 anti-obesity drugs before surgery
Most patients may continue to safely take glucagon-like peptide-1 (GLP-1) receptor agonists as prescribed before undergoing elective...
Multisociety clinical practice guidance says most patients can continue GLP-1 anti-obesity drugs before surgery
Multisociety clinical practice guidance says most patients can continue GLP-1 anti-obesity drugs before surgery
STEP 9: Semaglutide reduces knee osteoarthritis-related pain in people with obesity
Palatin completes study enrolment of bremelanotide plus tirzepatide to treat obesity
TENN-LABS: Ten-year outcomes show long-term benefits of surgery in young people
GT Metabolic's MagDI System for side-to-side DI anastomosis to "revolutionise industry" after FDA approval
One in five BMS patients benefit from preoperative ultrasound
Journal Watch 30/10/2024
Multisociety clinical practice guidance says most patients can continue GLP-1 anti-obesity drugs before surgery
Oxford Medical Products’ Sirona inert dual-polymer hydrogel pill can result in 10% TBWL
Bariatric patients see post-surgical increase in earnings out to five years
FDA grants De Novo approval for Distalmotion’s Dexter Surgical Robot for adult inguinal hernia repair
Semaglutide has positive effect in chronic kidney disease
GLP-1s: Second year cost of care is $4,200 higher for patients with obesity